Clinical efficacy of preoperative application of hydrochloride tirofiban in patients with acute coronary syndrome by percutaneous coronary intervention

( views:282, downloads:0 )
Author:
LI Wei-hong(Department of Cardiology, the People's Hospital of Anqiu,Anqiu ,Shandong 262100, China)
Journal Title:
Chinese Journal of Primary Medicine and Pharmacy
Issue:
Volume 19, Issue 20, 2012
DOI:
10.3760/cma.j.issn.1008-6706.2012.20.015
Key Word:
Hydrochloride tirofiban ;Acute coronary syndrome ;Angioplasty ,transluminal ,percutaneous coronary

Abstract: Objective To observe the clinical efficacy and application value of preoperative application of hydrochloride tirofiban in patients with acute coronary syndrome(ACS) by percutaneous coronary intervention (PCI).Methods 60 ACS patients underwent PIC surgery were randomly divided into observation group and control group.All patients underwent preoperative and postoperative regular routine anti-angina and acute myocardial infarction treatment,the observation group was given the hydrochloride tirofiban in 1h before surgery of emergency PCI,the control group received conventional therapy.The bleeding and thrombocytopenia occurrence during hospitalization of the two groups were observed,before surgery and 1 month after surgery the cardiac function of the two groups were compared,1 month after surgery the occurrence of adverse cardiovascular events were recorded.Results The bleeding incidence of observation group was 6.7%,the control group was 23.3%,the difference between two groups was significant ( x2 =15.594,P < 0.01 ) ; The thrombocytopenia occurrence of observation group was 3.3%,the control group was 10.0%,the difference between two groups was significant( x2 =13.366,P < 0.01 ).1 month after surgery the LVEF,CO and E/A of the two groups increased significantly,compared with the prior-treatment,the difference was significant (P < 0.05 ),and the difference was significant between the two groups( P < 0.05 ) ;The occurrence of adverse cardiovascular events of observation group was 33.3%,the control group was 66.7%,the difference between two groups was significant(x2 =8.924,P < 0.01 ).Conclusion The hydrochloride tirofiban is a safe and effective anti-platelet drugs.Preoperative application of hydrochloride tirofiban in patients with ACS by PCI can reduce the occurrence of cardiovascular events.

  • [1]Singh SK,Suresh MV,Voleti B,et al.The connection between Creactive protein and atherosclerosis.Ann Med,2008,40 (2):110-120.
  • [2]中华心血管病杂志编辑委员会.不稳定型心绞痛诊断和治疗建议.中华心血管病杂志,2000,28(6):409-412.
  • [3]索宝军,郑亚安.急性冠状动脉综合征的抗血小板治疗.实用心脑肺血管病杂志,2010,12(5):25-26.
  • [4]Kang Y,Lee JW,Koh YH,et al.New MRI grading system for the cervical canal stenosis.Am J Roentgenol,2011,197 (1):134-140.
  • [5]周艳萍,董美媛,方波.替罗非班联合急诊经皮冠状动脉介入治疗急性心肌梗死的不良事件观察和护理.中国基层医药,2011,18(22):3156-3157.
  • [6]唐强,霍勇,陈明,等.盐酸替罗非班对急性心肌梗死急诊经皮冠脉介入治疗中TIMI血流影响的临床研究.中国介入心脏病杂志,2006,12(1):97-99.
  • [7]Hegarty D,Oconnor OJ,Moore M,et al.Association between preoperative magnetic resonance imaging,pain intensity and quantitative sensory testing in patients awaiting lumbar diskectomy.J Med Imaging Radiat Oncol,2011,55(1):4-10.
  • [8]杨新春,徐立,王乐丰,等.国产替罗非班对急性心肌梗死患者急诊介入治疗术后冠状动脉血流和肌灌注影响的研究.中国循环杂志,2006,21(1):4-7.
  • [9]齐玉霞.大剂量阿托伐他汀联合替罗非班对急性冠脉综合征患者颈动脉粥样硬化的影响.中国基层医药,2012,19(5):703-705.
  • [10]Cibere J,Sayre EC,Guermazi A,et al.Natural history of cartilage damage and osteoarthritis progression on magnetic resonance imaging in a population-based cohort with knee pain.Osteoarthritis Cartilage,2011,19(6):683-688.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn